Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

Share Price is delayed by 15 minutes
Get Live Data
630.00    30.00 (5.00%)
Bid:
626.00
Ask:
634.00
Spread: 8.00 (1.278%)
Market Cap: £762.36m
OXB Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biomedica Share Chart

Block Listing Return

7 Jan 2020 10:17

RNS Number : 9931Y
Oxford Biomedica PLC
07 January 2020
 

For Immediate Release

07 January 2020

 

OXFORD BIOMEDICA PLC

 

BLOCK LISTING RETURN

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Employee Share Option Scheme

Period of return:

From:

1 July 2019

To:

31 December 2019

Balance of unallotted securities under scheme(s) from previous return:

31,157

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

20,301

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

10,856

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Long Term Incentive Plan

Period of return:

From:

1 July 2019

To:

31 December 2019

Balance of unallotted securities under scheme(s) from previous return:

270,875

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

NIL

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

270,875

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Deferred Bonus Plan

Period of return:

From:

1 July 2019

To:

31 December 2019

Balance of unallotted securities under scheme(s) from previous return:

102,346

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

NIL

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

102,346

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

Sharesave Scheme

Period of return:

From:

1 July 2019

To:

31 December 2019

Balance of unallotted securities under scheme(s) from previous return:

237,224

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

78,180

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

159,044

 

 

 

Name of contact:

Natalie Walter

Telephone number of contact:

01865 783000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRBRMMTMTBMBIM
Date   Source Headline
22nd Jan 202012:11 pmRNSBlock listing Application
7th Jan 202010:17 amRNSBlock Listing Return
2nd Jan 202011:41 amRNSTotal Voting Rights
19th Dec 20193:27 pmRNSDirector Dealings / Market Share Purchase
19th Dec 20197:00 amRNSExtension of Commercial Supply Agreement
2nd Dec 20199:31 amRNSTotal Voting Rights
27th Nov 201910:05 amRNSDirector Dealings / Market Share Purchase
13th Nov 20194:41 pmRNSHolding(s) in Company
1st Nov 20199:25 amRNSTotal Voting Rights
28th Oct 201912:30 pmRNSDirector Dealings / Market Share Purchase
23rd Oct 20197:00 amRNSHolding(s) in Company
23rd Oct 20197:00 amRNSHolding(s) in Company
16th Oct 20197:30 amEQSHardman & Co Research: Oxford BioMedica (OXB): Demanding second half
1st Oct 201910:18 amRNSTotal Voting Rights
25th Sep 201911:41 amRNSDirector Dealings / Market Share Purchase
16th Sep 201911:18 amRNSDirector/PDMR Shareholding
16th Sep 20199:15 amRNSDirectors Dealings / Market Share Purchases
13th Sep 20192:57 pmRNSLong Term Incentive Plan Option Grant
13th Sep 20191:13 pmRNSDirectors Dealings / Market Share Purchases
13th Sep 201910:53 amRNSDirector Dealings / Market Share Purchase
4th Sep 20197:00 amRNSOxford Biomedica Interim Results
2nd Sep 20199:31 amRNSTotal Voting Rights
23rd Aug 201911:06 amRNSDirector Dealings / Market Share Purchase
9th Aug 201912:00 pmRNSNotice of Interim Results
1st Aug 20199:18 amRNSTotal Voting Rights
25th Jul 20192:17 pmRNSDirector Dealings / Market Share Purchase
1st Jul 201911:04 amEQSHardman & Co Research: Oxford BioMedica (OXB): Eying up long-term value
1st Jul 201910:01 amRNSBlock listing Interim Review
1st Jul 20199:32 amRNSTotal Voting Rights
28th Jun 20197:00 amRNSRepayment of Debt Facility
26th Jun 20192:52 pmRNSDirector Dealings / Market Share Purchase
26th Jun 20197:00 amRNSOXB and Santen enter R&D collaboration
25th Jun 20197:00 amRNSBoard Change
18th Jun 20197:15 amEQSHardman & Co Research: Oxford BioMedica (OXB): De-leveraging the balance sheet
10th Jun 20192:34 pmRNSDirector/PDMR Shareholding
6th Jun 20191:08 pmRNSAxovant update on 1st cohort of Sunrise-PD trial
6th Jun 201911:39 amRNSHolding(s) in Company
5th Jun 201912:06 pmRNSHoldings in Company
4th Jun 20195:38 pmRNSHoldings in Company
4th Jun 20199:59 amRNSTotal Voting Rights
3rd Jun 20196:06 pmRNSHolding(s) in Company
3rd Jun 201910:31 amRNSTotal Voting Rights
29th May 20196:19 pmRNSExercise of Subscription Option by Novo Holdings
29th May 20191:06 pmRNSResult of AGM
28th May 20197:00 amRNSStrategic Investment by Novo Holdings A/S
23rd May 20196:04 pmRNSDirector Dealings / Market Share Purchase
2nd May 20192:53 pmRNSLong Term Incentive Plan Option Grant
1st May 201912:52 pmRNSREPLACEMENT: Total Voting Rights
1st May 201911:33 amRNSTotal Voting Rights
30th Apr 20195:38 pmRNSHoldings in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.